Delivery Order SPE2DB22D3301-SPE2DB25FY9FL
- Not listed
- The Defense Logistics Agency awarded a $3,477.50 delivery order to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays under a firm fixed price contract structure. The award was issued on July 28, 2025, with a completion date of July 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is executed as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,218.76 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This competitively awarded, firm fixed-price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor. The order...
- The Defense Logistics Agency awarded a delivery order valued at $2,965.52 to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays. This firm fixed-price, competitively awarded contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,391.00 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray. This firm fixed price contract, awarded on August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside designation and will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,974.41 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The award was issued on August 27, 2025, with performance to be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,998.29 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray, with an ultimate completion date of August 8, 2025. This firm fixed price, non-set-aside delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays under a firm fixed-price contract valued at $1,043.25, with an ultimate completion date of July 31, 2025. This non-set-aside contract represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray, valued at $2,086.50, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and reflects the agency's pharmaceutical procurement through its established medical supply chain. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9FLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,642.12 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Nayzilam is a rapid-acting benzodiazepine spray used for acute seizure management and represents the type of specialized pharmaceutical product within AmerisourceBergen's extensive federal medical supply portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. As a prime pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government medical systems by supplying a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet rigorous federal procurement requirements for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/12/25 |